Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inactivation of poliovirus.

W Hennessen

    Developments in Biological Standardization
    |January 1, 1981
    PubMed
    Summary

    Poliovirus inactivation kinetics depend on whether agents target RNA (first-order) or protein (second-order). Optimizing viral inactivation for vaccines requires balancing antigenicity with procedural safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Usage of animals in the European Pharmacopoeia (EP). A comparison between the first and second edition.

    Developments in biological standardization·1986
    Same author

    Replacement of animals in manufacture and control of vaccines.

    Developments in biological standardization·1980
    Same author

    The clinical uses of albumin: report of an IABS study.

    Developments in biological standardization·1980
    Same author

    Clinical requirements for albumin: report of an IABS study.

    Developments in biological standardization·1980
    Same author

    [Side effects of whooping cough inoculation].

    Fortschritte der Medizin·1979
    Same author

    Report of a working group for the European Pharmacopoeia. Collaborative assay on human albumin of different origin.

    Developments in biological standardization·1979

    Area of Science:

    • Virology
    • Biochemistry
    • Vaccine Development

    Background:

    • Poliovirus inactivation mechanisms were extensively studied in the mid-20th century.
    • Inactivation kinetics are influenced by the viral component targeted by inactivating agents.
    • Understanding these kinetics is crucial for developing safe and effective vaccines.

    Purpose of the Study:

    • To review the kinetics of poliovirus inactivation based on targeted viral structures.
    • To discuss the implications of different inactivation pathways for vaccine production.
    • To evaluate various inactivation technologies considering antigenicity and safety.

    Main Methods:

    • Analysis of historical data on poliovirus inactivation.
    • Comparison of first-order (RNA targeting) and second-order (protein targeting) inactivation reactions.
    • Review of chemical and physical factors influencing inactivation (temperature, pH, time).

    Main Results:

    • Poliovirus RNA inactivation follows first-order kinetics (single-hit).
    • Poliovirus protein inactivation follows second-order kinetics (multiple-hits).
    • Classical inactivating chemicals remain relevant for poliovaccines.

    Conclusions:

    • The choice of inactivating agent and conditions significantly impacts viral inactivation kinetics.
    • Balancing high antigenicity with minimal procedural harm is essential for vaccine efficacy and safety.
    • Ongoing research explores novel agents and technologies for viral inactivation.

    Related Experiment Videos